Glycomics Market Size, Share & Trends Report

Glycomics Market (2023 - 2030) Size, Share & Trends Analysis Report By Product (Enzymes, Kits, Reagents, Instruments), By Application (Drug Discovery & Development, Diagnostics), By End Use, By Region, And Segment Forecasts

Market Segmentation

Glycomics Product Scope Outlook (Revenue, USD Million, 2018 - 2030)
- Enzymes
  - Glycosidases
  - Neuraminidases
  - Glycosyltransferases
  - Sialyltransferases
  - Others
- Kits
  - Glycan Labeling Kits
  - Glycan Purification Kits
  - Glycan Release Kits
  - Others
- Reagents
  - Glycoproteins
  - Monosaccharides
  - Oligosaccharides
  - Others
- Instruments
  - Mass Spectrometers
  - HPLC
  - MALDI-TOF
  - Array Systems
  - Others
Glycomics Application Scope Outlook (Revenue, USD Million, 2018 - 2030)
- Drug Discovery & Development
- Diagnostics
- Others
Glycomics End-use Outlook (Revenue, USD Million, 2018 - 2030)
- Academic & Research Institutes
- Pharmaceutical & Biotechnology Companies
- Biopharmaceutical Companies
- CROs
Glycomics Regional Outlook (Revenue, USD Million; 2018 - 2030)
- North America
  - North America Product Outlook (Revenue, USD Million, 2018 - 2030)
    - Enzymes
      - Glycosidases
      - Neuraminidases
      - Glycosyltransferases
      - Sialyltransferases
      - Others
    - Kits
      - Glycan Labeling Kits
      - Glycan Purification Kits
      - Glycan Release Kits
      - Others
    - Reagents
      - Glycoproteins
      - Monosaccharides
      - Oligosaccharides
      - Others
    - Instruments
      - Mass Spectrometers
      - HPLC
      - MALDI-TOF
      - Array Systems
      - Others
  - North America Application Outlook (Revenue, USD Million, 2018 - 2030)
    - Drug Discovery & Development
    - Diagnostics
    - Others
  - North America End Use Outlook (Revenue, USD Million, 2018 - 2030)
    - Academic & Research Institutes
    - Pharmaceutical & Biotechnology Companies
    - Biopharmaceutical Companies
    - CROs
  - U.S.
    - U.S. Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Enzymes
        
        Glycosidases
        
        Neuraminidases
        
        Glycosyltransferases
        
        Sialyltransferases
        
        Others
      - Kits
        
        Glycan Labeling Kits
        
        Glycan Purification Kits
        
        Glycan Release Kits
        
        Others
      - Reagents
        
        Glycoproteins
        
        Monosaccharides
        
        Oligosaccharides
        
        Others
      - Instruments
        
        Mass Spectrometers
        
        HPLC
        
        MALDI-TOF
        
        Array Systems
        
        Others
    - U.S. Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Drug Discovery & Development
      - Diagnostics
      - Others
    - U.S. End Use Outlook (Revenue, USD Million, 2018 - 2030)
      - Academic & Research Institutes
      - Pharmaceutical & Biotechnology Companies
      - Biopharmaceutical Companies
      - CROs
  - Canada
    - Canada Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Enzymes
        
        Glycosidases
        
        Neuraminidases
        
        Glycosyltransferases
        
        Sialyltransferases
        
        Others
      - Kits
        
        Glycan Labeling Kits
        
        Glycan Purification Kits
        
        Glycan Release Kits
        
        Others
      - Reagents
        
        Glycoproteins
        
        Monosaccharides
        
        Oligosaccharides
        
        Others
      - Instruments
        
        Mass Spectrometers
        
        HPLC
        
        MALDI-TOF
        
        Array Systems
        
        Others
    - Canada Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Drug Discovery & Development
      - Diagnostics
      - Others
    - Canada End Use Outlook (Revenue, USD Million, 2018 - 2030)
      - Academic & Research Institutes
      - Pharmaceutical & Biotechnology Companies
      - Biopharmaceutical Companies
      - CROs
- Europe
  - Europe Product Outlook (Revenue, USD Million, 2018 - 2030)
    - Enzymes
      - Glycosidases
      - Neuraminidases
      - Glycosyltransferases
      - Sialyltransferases
      - Others
    - Kits
      - Glycan Labeling Kits
      - Glycan Purification Kits
      - Glycan Release Kits
      - Others
    - Reagents
      - Glycoproteins
      - Monosaccharides
      - Oligosaccharides
      - Others
    - Instruments
      - Mass Spectrometers
      - HPLC
      - MALDI-TOF
      - Array Systems
      - Others
  - Europe Application Outlook (Revenue, USD Million, 2018 - 2030)
    - Drug Discovery & Development
    - Diagnostics
    - Others
  - Europe End Use Outlook (Revenue, USD Million, 2018 - 2030)
    - Academic & Research Institutes
    - Pharmaceutical & Biotechnology Companies
    - Biopharmaceutical Companies
    - CROs
  - Germany
    - Germany Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Enzymes
        
        Glycosidases
        
        Neuraminidases
        
        Glycosyltransferases
        
        Sialyltransferases
        
        Others
      - Kits
        
        Glycan Labeling Kits
        
        Glycan Purification Kits
        
        Glycan Release Kits
        
        Others
      - Reagents
        
        Glycoproteins
        
        Monosaccharides
        
        Oligosaccharides
        
        Others
      - Instruments
        
        Mass Spectrometers
        
        HPLC
        
        MALDI-TOF
        
        Array Systems
        
        Others
    - Germany Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Drug Discovery & Development
      - Diagnostics
      - Others
    - Germany End Use Outlook (Revenue, USD Million, 2018 - 2030)
      - Academic & Research Institutes
      - Pharmaceutical & Biotechnology Companies
      - Biopharmaceutical Companies
      - CROs
  - UK
    - UK Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Enzymes
        
        Glycosidases
        
        Neuraminidases
        
        Glycosyltransferases
        
        Sialyltransferases
        
        Others
      - Kits
        
        Glycan Labeling Kits
        
        Glycan Purification Kits
        
        Glycan Release Kits
        
        Others
      - Reagents
        
        Glycoproteins
        
        Monosaccharides
        
        Oligosaccharides
        
        Others
      - Instruments
        
        Mass Spectrometers
        
        HPLC
        
        MALDI-TOF
        
        Array Systems
        
        Others
    - UK Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Drug Discovery & Development
      - Diagnostics
      - Others
    - UK End Use Outlook (Revenue, USD Million, 2018 - 2030)
      - Academic & Research Institutes
      - Pharmaceutical & Biotechnology Companies
      - Biopharmaceutical Companies
      - CROs
  - France
    - France Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Enzymes
        
        Glycosidases
        
        Neuraminidases
        
        Glycosyltransferases
        
        Sialyltransferases
        
        Others
      - Kits
        
        Glycan Labeling Kits
        
        Glycan Purification Kits
        
        Glycan Release Kits
        
        Others
      - Reagents
        
        Glycoproteins
        
        Monosaccharides
        
        Oligosaccharides
        
        Others
      - Instruments
        
        Mass Spectrometers
        
        HPLC
        
        MALDI-TOF
        
        Array Systems
        
        Others
    - France Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Drug Discovery & Development
      - Diagnostics
      - Others
    - France End Use Outlook (Revenue, USD Million, 2018 - 2030)
      - Academic & Research Institutes
      - Pharmaceutical & Biotechnology Companies
      - Biopharmaceutical Companies
      - CROs
  - Italy
    - Italy Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Enzymes
        
        Glycosidases
        
        Neuraminidases
        
        Glycosyltransferases
        
        Sialyltransferases
        
        Others
      - Kits
        
        Glycan Labeling Kits
        
        Glycan Purification Kits
        
        Glycan Release Kits
        
        Others
      - Reagents
        
        Glycoproteins
        
        Monosaccharides
        
        Oligosaccharides
        
        Others
      - Instruments
        
        Mass Spectrometers
        
        HPLC
        
        MALDI-TOF
        
        Array Systems
        
        Others
    - Italy Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Drug Discovery & Development
      - Diagnostics
      - Others
    - Italy End Use Outlook (Revenue, USD Million, 2018 - 2030)
      - Academic & Research Institutes
      - Pharmaceutical & Biotechnology Companies
      - Biopharmaceutical Companies
      - CROs
  - Spain
    - Spain Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Enzymes
        
        Glycosidases
        
        Neuraminidases
        
        Glycosyltransferases
        
        Sialyltransferases
        
        Others
      - Kits
        
        Glycan Labeling Kits
        
        Glycan Purification Kits
        
        Glycan Release Kits
        
        Others
      - Reagents
        
        Glycoproteins
        
        Monosaccharides
        
        Oligosaccharides
        
        Others
      - Instruments
        
        Mass Spectrometers
        
        HPLC
        
        MALDI-TOF
        
        Array Systems
        
        Others
    - Spain Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Drug Discovery & Development
      - Diagnostics
      - Others
    - Spain End Use Outlook (Revenue, USD Million, 2018 - 2030)
      - Academic & Research Institutes
      - Pharmaceutical & Biotechnology Companies
      - Biopharmaceutical Companies
      - CROs
  - Denmark
    - Denmark Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Enzymes
        
        Glycosidases
        
        Neuraminidases
        
        Glycosyltransferases
        
        Sialyltransferases
        
        Others
      - Kits
        
        Glycan Labeling Kits
        
        Glycan Purification Kits
        
        Glycan Release Kits
        
        Others
      - Reagents
        
        Glycoproteins
        
        Monosaccharides
        
        Oligosaccharides
        
        Others
      - Instruments
        
        Mass Spectrometers
        
        HPLC
        
        MALDI-TOF
        
        Array Systems
        
        Others
    - Denmark Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Drug Discovery & Development
      - Diagnostics
      - Others
    - Denmark End Use Outlook (Revenue, USD Million, 2018 - 2030)
      - Academic & Research Institutes
      - Pharmaceutical & Biotechnology Companies
      - Biopharmaceutical Companies
      - CROs
  - Sweden
    - Sweden Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Enzymes
        
        Glycosidases
        
        Neuraminidases
        
        Glycosyltransferases
        
        Sialyltransferases
        
        Others
      - Kits
        
        Glycan Labeling Kits
        
        Glycan Purification Kits
        
        Glycan Release Kits
        
        Others
      - Reagents
        
        Glycoproteins
        
        Monosaccharides
        
        Oligosaccharides
        
        Others
      - Instruments
        
        Mass Spectrometers
        
        HPLC
        
        MALDI-TOF
        
        Array Systems
        
        Others
    - Sweden Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Drug Discovery & Development
      - Diagnostics
      - Others
    - Sweden End Use Outlook (Revenue, USD Million, 2018 - 2030)
      - Academic & Research Institutes
      - Pharmaceutical & Biotechnology Companies
      - Biopharmaceutical Companies
      - CROs
  - Norway
    - Norway Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Enzymes
        
        Glycosidases
        
        Neuraminidases
        
        Glycosyltransferases
        
        Sialyltransferases
        
        Others
      - Kits
        
        Glycan Labeling Kits
        
        Glycan Purification Kits
        
        Glycan Release Kits
        
        Others
      - Reagents
        
        Glycoproteins
        
        Monosaccharides
        
        Oligosaccharides
        
        Others
      - Instruments
        
        Mass Spectrometers
        
        HPLC
        
        MALDI-TOF
        
        Array Systems
        
        Others
    - Norway Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Drug Discovery & Development
      - Diagnostics
      - Others
    - Norway End Use Outlook (Revenue, USD Million, 2018 - 2030)
      - Academic & Research Institutes
      - Pharmaceutical & Biotechnology Companies
      - Biopharmaceutical Companies
      - CROs
- Asia Pacific
  - Asia Pacific Product Outlook (Revenue, USD Million, 2018 - 2030)
    - Enzymes
      - Glycosidases
      - Neuraminidases
      - Glycosyltransferases
      - Sialyltransferases
      - Others
    - Kits
      - Glycan Labeling Kits
      - Glycan Purification Kits
      - Glycan Release Kits
      - Others
    - Reagents
      - Glycoproteins
      - Monosaccharides
      - Oligosaccharides
      - Others
    - Instruments
      - Mass Spectrometers
      - HPLC
      - MALDI-TOF
      - Array Systems
      - Others
  - Asia Pacific Application Outlook (Revenue, USD Million, 2018 - 2030)
    - Drug Discovery & Development
    - Diagnostics
    - Others
  - Asia Pacific End Use Outlook (Revenue, USD Million, 2018 - 2030)
    - Academic & Research Institutes
    - Pharmaceutical & Biotechnology Companies
    - Biopharmaceutical Companies
    - CROs
  - China
    - China Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Enzymes
        
        Glycosidases
        
        Neuraminidases
        
        Glycosyltransferases
        
        Sialyltransferases
        
        Others
      - Kits
        
        Glycan Labeling Kits
        
        Glycan Purification Kits
        
        Glycan Release Kits
        
        Others
      - Reagents
        
        Glycoproteins
        
        Monosaccharides
        
        Oligosaccharides
        
        Others
      - Instruments
        
        Mass Spectrometers
        
        HPLC
        
        MALDI-TOF
        
        Array Systems
        
        Others
    - China Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Drug Discovery & Development
      - Diagnostics
      - Others
    - China End Use Outlook (Revenue, USD Million, 2018 - 2030)
      - Academic & Research Institutes
      - Pharmaceutical & Biotechnology Companies
      - Biopharmaceutical Companies
      - CROs
  - India
    - India Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Enzymes
        
        Glycosidases
        
        Neuraminidases
        
        Glycosyltransferases
        
        Sialyltransferases
        
        Others
      - Kits
        
        Glycan Labeling Kits
        
        Glycan Purification Kits
        
        Glycan Release Kits
        
        Others
      - Reagents
        
        Glycoproteins
        
        Monosaccharides
        
        Oligosaccharides
        
        Others
      - Instruments
        
        Mass Spectrometers
        
        HPLC
        
        MALDI-TOF
        
        Array Systems
        
        Others
    - India Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Drug Discovery & Development
      - Diagnostics
      - Others
    - India End Use Outlook (Revenue, USD Million, 2018 - 2030)
      - Academic & Research Institutes
      - Pharmaceutical & Biotechnology Companies
      - Biopharmaceutical Companies
      - CROs
  - Japan
    - Japan Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Enzymes
        
        Glycosidases
        
        Neuraminidases
        
        Glycosyltransferases
        
        Sialyltransferases
        
        Others
      - Kits
        
        Glycan Labeling Kits
        
        Glycan Purification Kits
        
        Glycan Release Kits
        
        Others
      - Reagents
        
        Glycoproteins
        
        Monosaccharides
        
        Oligosaccharides
        
        Others
      - Instruments
        
        Mass Spectrometers
        
        HPLC
        
        MALDI-TOF
        
        Array Systems
        
        Others
    - Japan Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Drug Discovery & Development
      - Diagnostics
      - Others
    - Japan End Use Outlook (Revenue, USD Million, 2018 - 2030)
      - Academic & Research Institutes
      - Pharmaceutical & Biotechnology Companies
      - Biopharmaceutical Companies
      - CROs
  - South Korea
    - South Korea Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Enzymes
        
        Glycosidases
        
        Neuraminidases
        
        Glycosyltransferases
        
        Sialyltransferases
        
        Others
      - Kits
        
        Glycan Labeling Kits
        
        Glycan Purification Kits
        
        Glycan Release Kits
        
        Others
      - Reagents
        
        Glycoproteins
        
        Monosaccharides
        
        Oligosaccharides
        
        Others
      - Instruments
        
        Mass Spectrometers
        
        HPLC
        
        MALDI-TOF
        
        Array Systems
        
        Others
    - South Korea Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Drug Discovery & Development
      - Diagnostics
      - Others
    - South Korea End Use Outlook (Revenue, USD Million, 2018 - 2030)
      - Academic & Research Institutes
      - Pharmaceutical & Biotechnology Companies
      - Biopharmaceutical Companies
      - CROs
  - Australia
    - Australia Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Enzymes
        
        Glycosidases
        
        Neuraminidases
        
        Glycosyltransferases
        
        Sialyltransferases
        
        Others
      - Kits
        
        Glycan Labeling Kits
        
        Glycan Purification Kits
        
        Glycan Release Kits
        
        Others
      - Reagents
        
        Glycoproteins
        
        Monosaccharides
        
        Oligosaccharides
        
        Others
      - Instruments
        
        Mass Spectrometers
        
        HPLC
        
        MALDI-TOF
        
        Array Systems
        
        Others
    - Australia Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Drug Discovery & Development
      - Diagnostics
      - Others
    - Australia End Use Outlook (Revenue, USD Million, 2018 - 2030)
      - Academic & Research Institutes
      - Pharmaceutical & Biotechnology Companies
      - Biopharmaceutical Companies
      - CROs
  - Thailand
    - Thailand Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Enzymes
        
        Glycosidases
        
        Neuraminidases
        
        Glycosyltransferases
        
        Sialyltransferases
        
        Others
      - Kits
        
        Glycan Labeling Kits
        
        Glycan Purification Kits
        
        Glycan Release Kits
        
        Others
      - Reagents
        
        Glycoproteins
        
        Monosaccharides
        
        Oligosaccharides
        
        Others
      - Instruments
        
        Mass Spectrometers
        
        HPLC
        
        MALDI-TOF
        
        Array Systems
        
        Others
    - Thailand Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Drug Discovery & Development
      - Diagnostics
      - Others
    - Thailand End Use Outlook (Revenue, USD Million, 2018 - 2030)
      - Academic & Research Institutes
      - Pharmaceutical & Biotechnology Companies
      - Biopharmaceutical Companies
      - CROs
  - South Korea
    - South Korea Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Enzymes
        
        Glycosidases
        
        Neuraminidases
        
        Glycosyltransferases
        
        Sialyltransferases
        
        Others
      - Kits
        
        Glycan Labeling Kits
        
        Glycan Purification Kits
        
        Glycan Release Kits
        
        Others
      - Reagents
        
        Glycoproteins
        
        Monosaccharides
        
        Oligosaccharides
        
        Others
      - Instruments
        
        Mass Spectrometers
        
        HPLC
        
        MALDI-TOF
        
        Array Systems
        
        Others
    - South Korea Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Drug Discovery & Development
      - Diagnostics
      - Others
    - South Korea End Use Outlook (Revenue, USD Million, 2018 - 2030)
      - Academic & Research Institutes
      - Pharmaceutical & Biotechnology Companies
      - Biopharmaceutical Companies
      - CROs
- Latin America
  - Latin America Product Outlook (Revenue, USD Million, 2018 - 2030)
    - Enzymes
      - Glycosidases
      - Neuraminidases
      - Glycosyltransferases
      - Sialyltransferases
      - Others
    - Kits
      - Glycan Labeling Kits
      - Glycan Purification Kits
      - Glycan Release Kits
      - Others
    - Reagents
      - Glycoproteins
      - Monosaccharides
      - Oligosaccharides
      - Others
    - Instruments
      - Mass Spectrometers
      - HPLC
      - MALDI-TOF
      - Array Systems
      - Others
  - Latin America Application Outlook (Revenue, USD Million, 2018 - 2030)
    - Drug Discovery & Development
    - Diagnostics
    - Others
  - Latin America End Use Outlook (Revenue, USD Million, 2018 - 2030)
    - Academic & Research Institutes
    - Pharmaceutical & Biotechnology Companies
    - Biopharmaceutical Companies
    - CROs
  - Brazil
    - Brazil Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Enzymes
        
        Glycosidases
        
        Neuraminidases
        
        Glycosyltransferases
        
        Sialyltransferases
        
        Others
      - Kits
        
        Glycan Labeling Kits
        
        Glycan Purification Kits
        
        Glycan Release Kits
        
        Others
      - Reagents
        
        Glycoproteins
        
        Monosaccharides
        
        Oligosaccharides
        
        Others
      - Instruments
        
        Mass Spectrometers
        
        HPLC
        
        MALDI-TOF
        
        Array Systems
        
        Others
    - Brazil Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Drug Discovery & Development
      - Diagnostics
      - Others
    - Brazil End Use Outlook (Revenue, USD Million, 2018 - 2030)
      - Academic & Research Institutes
      - Pharmaceutical & Biotechnology Companies
      - Biopharmaceutical Companies
      - CROs
  - Mexico
    - Mexico Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Enzymes
        
        Glycosidases
        
        Neuraminidases
        
        Glycosyltransferases
        
        Sialyltransferases
        
        Others
      - Kits
        
        Glycan Labeling Kits
        
        Glycan Purification Kits
        
        Glycan Release Kits
        
        Others
      - Reagents
        
        Glycoproteins
        
        Monosaccharides
        
        Oligosaccharides
        
        Others
      - Instruments
        
        Mass Spectrometers
        
        HPLC
        
        MALDI-TOF
        
        Array Systems
        
        Others
    - Mexico Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Drug Discovery & Development
      - Diagnostics
      - Others
    - Mexico End Use Outlook (Revenue, USD Million, 2018 - 2030)
      - Academic & Research Institutes
      - Pharmaceutical & Biotechnology Companies
      - Biopharmaceutical Companies
      - CROs
  - Argentina
    - Argentina Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Enzymes
        
        Glycosidases
        
        Neuraminidases
        
        Glycosyltransferases
        
        Sialyltransferases
        
        Others
      - Kits
        
        Glycan Labeling Kits
        
        Glycan Purification Kits
        
        Glycan Release Kits
        
        Others
      - Reagents
        
        Glycoproteins
        
        Monosaccharides
        
        Oligosaccharides
        
        Others
      - Instruments
        
        Mass Spectrometers
        
        HPLC
        
        MALDI-TOF
        
        Array Systems
        
        Others
    - Argentina Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Drug Discovery & Development
      - Diagnostics
      - Others
    - Argentina End Use Outlook (Revenue, USD Million, 2018 - 2030)
      - Academic & Research Institutes
      - Pharmaceutical & Biotechnology Companies
      - Biopharmaceutical Companies
      - CROs
- Middle East and Africa (MEA)
  - Middle East and Africa (MEA) Product Outlook (Revenue, USD Million, 2018 - 2030)
    - Enzymes
      - Glycosidases
      - Neuraminidases
      - Glycosyltransferases
      - Sialyltransferases
      - Others
    - Kits
      - Glycan Labeling Kits
      - Glycan Purification Kits
      - Glycan Release Kits
      - Others
    - Reagents
      - Glycoproteins
      - Monosaccharides
      - Oligosaccharides
      - Others
    - Instruments
      - Mass Spectrometers
      - HPLC
      - MALDI-TOF
      - Array Systems
      - Others
  - Middle East and Africa (MEA) Application Outlook (Revenue, USD Million, 2018 - 2030)
    - Drug Discovery & Development
    - Diagnostics
    - Others
  - Middle East and Africa (MEA) End Use Outlook (Revenue, USD Million, 2018 - 2030)
    - Academic & Research Institutes
    - Pharmaceutical & Biotechnology Companies
    - Biopharmaceutical Companies
    - CROs
  - South Africa
    - South Africa Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Enzymes
        
        Glycosidases
        
        Neuraminidases
        
        Glycosyltransferases
        
        Sialyltransferases
        
        Others
      - Kits
        
        Glycan Labeling Kits
        
        Glycan Purification Kits
        
        Glycan Release Kits
        
        Others
      - Reagents
        
        Glycoproteins
        
        Monosaccharides
        
        Oligosaccharides
        
        Others
      - Instruments
        
        Mass Spectrometers
        
        HPLC
        
        MALDI-TOF
        
        Array Systems
        
        Others
    - South Africa Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Drug Discovery & Development
      - Diagnostics
      - Others
    - South Africa End Use Outlook (Revenue, USD Million, 2018 - 2030)
      - Academic & Research Institutes
      - Pharmaceutical & Biotechnology Companies
      - Biopharmaceutical Companies
      - CROs
  - Saudi Arabia
    - Saudi Arabia Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Enzymes
        
        Glycosidases
        
        Neuraminidases
        
        Glycosyltransferases
        
        Sialyltransferases
        
        Others
      - Kits
        
        Glycan Labeling Kits
        
        Glycan Purification Kits
        
        Glycan Release Kits
        
        Others
      - Reagents
        
        Glycoproteins
        
        Monosaccharides
        
        Oligosaccharides
        
        Others
      - Instruments
        
        Mass Spectrometers
        
        HPLC
        
        MALDI-TOF
        
        Array Systems
        
        Others
    - Saudi Arabia Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Drug Discovery & Development
      - Diagnostics
      - Others
    - Saudi Arabia End Use Outlook (Revenue, USD Million, 2018 - 2030)
      - Academic & Research Institutes
      - Pharmaceutical & Biotechnology Companies
      - Biopharmaceutical Companies
      - CROs
  - UAE
    - UAE Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Enzymes
        
        Glycosidases
        
        Neuraminidases
        
        Glycosyltransferases
        
        Sialyltransferases
        
        Others
      - Kits
        
        Glycan Labeling Kits
        
        Glycan Purification Kits
        
        Glycan Release Kits
        
        Others
      - Reagents
        
        Glycoproteins
        
        Monosaccharides
        
        Oligosaccharides
        
        Others
      - Instruments
        
        Mass Spectrometers
        
        HPLC
        
        MALDI-TOF
        
        Array Systems
        
        Others
    - UAE Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Drug Discovery & Development
      - Diagnostics
      - Others
    - UAE End Use Outlook (Revenue, USD Million, 2018 - 2030)
      - Academic & Research Institutes
      - Pharmaceutical & Biotechnology Companies
      - Biopharmaceutical Companies
      - CROs
  - Kuwait
    - Kuwait Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Enzymes
        
        Glycosidases
        
        Neuraminidases
        
        Glycosyltransferases
        
        Sialyltransferases
        
        Others
      - Kits
        
        Glycan Labeling Kits
        
        Glycan Purification Kits
        
        Glycan Release Kits
        
        Others
      - Reagents
        
        Glycoproteins
        
        Monosaccharides
        
        Oligosaccharides
        
        Others
      - Instruments
        
        Mass Spectrometers
        
        HPLC
        
        MALDI-TOF
        
        Array Systems
        
        Others
    - Kuwait Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Drug Discovery & Development
      - Diagnostics
      - Others
    - Kuwait End Use Outlook (Revenue, USD Million, 2018 - 2030)
      - Academic & Research Institutes
      - Pharmaceutical & Biotechnology Companies
      - Biopharmaceutical Companies
      - CROs

Report content

Qualitative Analysis

Industry overview
Industry trends
Market drivers and restraints
Market size
Growth prospects
Porter’s analysis
PESTEL analysis
Key market opportunities prioritized
Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments